DIREXION SHS ETF TR - DAILY PHARMA (PILL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / DAILY PHARMA
Symbol
PILL
Price per share
$12.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
261,443
Total reported value
$2,109,847
% of total 13F portfolios
0%
Share change
+121,167
Value change
+$977,624
Number of holders
7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 7 institutional investors reported holding 261,443 shares of DIREXION SHS ETF TR - DAILY PHARMA (PILL).

Institutional Holders of DIREXION SHS ETF TR - DAILY PHARMA (PILL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 100 $1,230 $12.30 1
2025 Q3 261,443 $2,109,847 +$977,624 $8.07 7
2025 Q2 140,276 $725,232 -$292,030 $5.17 5
2025 Q1 192,784 $1,391,902 +$1,391,881 $7.22 6
2024 Q4 1,003 $7,026 -$954,155 $7.00 3
2024 Q3 117,326 $961,881 +$350,893 $8.20 5
2024 Q2 76,354 $474,701 +$463,310 $6.22 4
2024 Q1 1,866 $15,121 -$1,333,996 $8.22 3
2023 Q4 174,120 $1,349,120 +$1,348,223 $7.75 5
2023 Q3 100 $897 -$8 $8.97 1
2023 Q2 401 $2,800 -$152,732 $7.92 3
2023 Q1 18,189 $155,532 -$318,142 $8.56 3
2022 Q4 54,941 $493,300 +$388,846 $8.97 5
2022 Q3 11,415 $101,000 -$1,272,046 $8.85 2
2022 Q2 134,019 $1,449,000 -$429,209 $10.81 5
2022 Q1 173,774 $2,515,000 -$1,431,479 $14.48 5
2021 Q4 251,952 $4,175,000 +$2,277,000 $15.88 6
2021 Q3 41,897 $742,000 -$1,499,041 $17.71 1
2021 Q2 101,352 $2,398,000 +$2,398,000 $23.66 4
2021 Q1 0 $0 -$667,000 $12.30 0
2020 Q4 26,323 $667,000 -$1,297,745 $25.33 2
2020 Q3 89,233 $1,374,000 -$870,238 $15.40 2
2020 Q2 168,265 $2,594,000 +$974,226 $15.41 5
2020 Q1 93,189 $921,000 -$1,137,748 $9.93 4
2019 Q4 125,433 $3,169,000 +$2,778,546 $25.26 5
2019 Q3 15,441 $192,000 -$646,117 $12.43 1
2019 Q2 47,048 $849,000 +$183,657 $17.94 2
2019 Q1 36,850 $873,000 +$625,000 $23.69 1
2018 Q4 11,640 $248,000 -$481,405 $21.31 1
2018 Q3 29,024 $1,073,000 -$1,001,310 $36.90 2
2018 Q2 56,232 $1,622,000 +$699,478 $28.85 2
2018 Q1 31,939 $754,000 +$455,648 $23.61 1
2017 Q4 12,638 $344,000 +$344,000 $27.22 1